For the Inventor, By the Inventor

Enter inventor name

San Diego, CA, United States of America

Stephen W Kaldor

USPTO Granted Patents = 66 (Patent Applications = 14)

CIPO Patents = 3 (Patent Applications = 12)

EPO Patents = 19 (Patent Applications = 21)

Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 229(Granted Patents)

Forward Citations (Not Self Cited) = 129(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Del Mar, CA (US) (2011 - 2013)
San Diego, CA (US) (2008 - 2024)
San Francisco, CA (US) (2023 - 2024)
Foster City, CA (US) (2024)

Company Filing History:

Celgene Quanticel Research, Inc.

11 out of 1,179

Takeda Pharmaceutical Company Limited

Kinnate Biopharma Inc.

Takeda San Diego, Inc.

Quanticel Pharmaceuticals, Inc.

Esker Therapeutics, Inc.

10. 1 out of 266

Pierre Fabre Medicament

Khora Spv 1, LLC

Takeda Pharmaceutical Company Limied

13. 2 out of 832,843

Other

patents

Years Active: 2008-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

PARP1 Inhibitors

TYK2 Inhibitors

RAF Kinase Inhibitors

MK2 Inhibitors

Lysine Specific Demethylase-1

Bromodomain Inhibitors

Cyclin-Dependent Kinase Inhibitors

Fibroblast Growth Factor Receptor Kinase Inhibitors

Antibacterial Agents

1,2,4-Triazoles

Pyridines

Pyridinones

66 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12421241 - Substituted pyridines as PARP1 inhibitors (2025-09-23),

2. 12384780 - PARP1 inhibitors and uses thereof (2025-08-12),

3. 12351572 - Substituted 1,2,4-triazoles as TYK2 inhibitors (2025-07-08),

4. 12331039 - Inhibitors of fibroblast growth factor receptor kinases (2025-06-17),

5. 12312336 - Inhibitors of RAF kinases (2025-05-27),

6. 12139462 - Pyridinone MK2 inhibitors and uses thereof (2024-11-12),

7. 12060343 - Substituted 1,2,4-triazoles as intermediates in the synthesis of TYK2 inhibitors (2024-08-13),

8. 12006322 - Substituted pyridines as PARP1 inhibitors (2024-06-11),

9. 12006306 - Substituted pyridazines as TYK2 inhibitors (2024-06-11),

10. 11987574 - MK2 inhibitors and uses thereof (2024-05-21),

11. 11987560 - Inhibitors of lysine specific demethylase-1 (2024-05-21),

12. 11939329 - PARP1 inhibitors and uses thereof (2024-03-26),

13. 11802128 - Azetidine and pyrrolidine PARP1 inhibitors and uses thereof (2023-10-31),

14. 11795173 - Substituted pyridines as PARP1 inhibitors (2023-10-24),

15. 11746095 - Inhibtors of RAF kinases (2023-09-05),

Title: The Innovative Journey of Stephen W Kaldor

Introduction: Stephen W Kaldor, a visionary inventor based in San Diego, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Stephen W Kaldor holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology. His most recent patent focuses on developing a cutting-edge sustainable energy solution for urban environments.

Career Highlights: With a career spanning over two decades, Stephen W Kaldor has established himself as a leading figure in the tech industry. His innovative solutions have not only revolutionized existing technologies but have also paved the way for future advancements in the field.

Collaborations: Throughout his career, Stephen W Kaldor has collaborated with top research institutions, leading companies, and renowned universities to further his research and bring his inventions to life. His collaborative efforts have resulted in groundbreaking technologies that have had a lasting impact on society.

Conclusion: Stephen W Kaldor's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his position as a trailblazing inventor in the industry. His contributions continue to inspire future generations of inventors and shape the technological landscape for years to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…